Financials
- Market Capitalization 612.15 M
- Employee 196
- Founded 2013
- CEO N/A
- Website www.4dmoleculartherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QG40R88
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3.1
売上高対価格比率
5.1
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2773 | MDXG MiMedx Group, Inc - Common Stock | 4.21 USD | +3.19% | +0.24% | +15.34% | -32.75% | 627.06 M USD | ||
| 2779 | NGNE Neurogene Inc. - Common Stock | 39.14 USD | +2.14% | +6.36% | +33.40% | +33.04% | 618.49 M USD | ||
| 2795 | FBRX Forte Biosciences, Inc. - Common Stock | 43.39 USD | -1.65% | +95.01% | +144.59% | +47.84% | 602.50 M USD | ||
| 2823 | IMMX Immix Biopharma, Inc. - Common Stock | 10.68 USD | +1.52% | -11.15% | +24.48% | +268.28% | 581.11 M USD |